Cannabis legalization spurs innovation, but not always in ways that benefit patients or public health
Cannabis legalization innovation has accelerated product development but not always in ways that benefit patients or public health. This innovation often prioritizes market growth over therapeutic efficacy and patient safety. Clinicians must navigate…
Editorial: New York’s Cannabis-Related Toxicity Challenges
Cannabis-related toxicity is an emerging concern following New York's legalization of recreational cannabis. Rising emergency department visits and poison control calls highlight the need for updated clinical protocols. Clinicians must recognize and…
Trends in Cannabis Urine Drug Screen Testing in Colorado’s Largest Health System
This study examines cannabis urine drug screen testing trends in Colorado's largest health system. It highlights demographic disparities in testing practices. Cannabis urine drug screen testing rates and positivity have shifted significantly since…
Pennsylvania Governor Advances Cannabis Legalization Efforts (Newsletter: April 8, 2026)
The Pennsylvania cannabis legalization update highlights the governor's intensified efforts in 2026 to advance cannabis laws. This update is critical for clinicians monitoring evolving state policies affecting medical cannabis. Understanding these…
Germany’s Cannabis Act Two Years On — What Government Data Shows
Germany cannabis legalization data from two years post-legalization reveals evolving patient access and clinical utilization patterns. The government data highlights regulatory impacts on product availability and safety monitoring. These insights inform…
Pennsylvania Governor Steps Up Cannabis Legalization Efforts (April 2026)
The 2026 cannabis legalization push in Pennsylvania is gaining momentum, impacting over 13 million residents. This policy shift could change patient access to cannabis medicine significantly. Clinicians should monitor these developments closely for…
More Weed, Less Crime? Exploring Cannabis Legalization’s Impact
The cannabis legalization impact on crime rates is a critical public health topic. Recent studies suggest legalization may reduce certain crime categories. Clinicians can use this data to guide patient counseling about legal cannabis use.
Does Cannabis Legalization Contribute to Lower Crime Rates? | Trending – Labroots
Cannabis legalization crime rates data influence policy discussions affecting patient access to cannabis medicine. Studies show no increase or modest decreases in crime after legalization. Understanding these effects helps clinicians advocate for…
Cannabis Legalisation Linked to More Adult Use and Increased Acute Harms, Review Finds
This review highlights the cannabis legalisation public health impact, showing increased adult use and acute harms. Pediatric poisonings rose sharply after edibles became available. Adolescent use trends remain mixed, with long-term effects still unclear.
Cannabis Legalisation Linked to More Use Among Adults and More Emergency Harms—But Adolescent Use Appears Largely Unchanged
Paediatric cannabis poisoning increase is a significant concern after cannabis legalisation. Emergency department visits for poisoning have risen sharply, especially among children. Adult cannabis use has increased modestly, while adolescent use remains…
